Huse and colleagues were able to show that miR-26 targets and induces the degradation of PTEN in high grade glioma tumors [7] and Liu in 2012 demonstrated that mir-26a overexpression enhances migration and invasion process through wound healing and invasion chamber assays respectively, in lung cancer cells by targeting PTEN [29]. This evidence concerns the gene PTEN and central nervous system cancer.